Company profile

OpenEvidence

OpenEvidence has raised a total of $300 million in funding over multiple rounds, achieving unicorn status in February 2025. Its latest Series B round of $210 million, closed on July 15, 2025, was led by Thrive Capital and Coatue. Founded in 2021 and headquartered in Cambridge, United States, OpenEvidence provides an AI-powered medical search platform for healthcare professionals, aggregating and visualizing clinical evidence to support informed decision-making. With 11–50 employees, the company continues to expand globally in the healthcare IT sector.

Back to profiles

Quick facts

Total funding: $300 million
Founded: 2021
Headquarters: Cambridge, United States, OpenEvidence provides an AI-powered medical search platform for healthcare professionals
Employees: 11 to 50

Notable investors

Thrive Capital
Coatue

Reach buyers like OpenEvidence on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like OpenEvidence
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like OpenEvidence.

The 14-day trial ships every feature, no card required.

Start free →